In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d

Authors

Tess Allan (ORCID: https://orcid.org/0000-0002-3384-1135)
L. Kristin Newby

Institutions

Duke University (US)

Publication Details

Journal: Annals of Internal Medicine
Published: 2026-01-01
DOI: https://doi.org/10.7326/annals-25-05115-jc
Primary Topic: Lipoproteins and Cardiovascular Health
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d

Tess Allan, L. Kristin Newby

Jan 1, 2026

Annals of Internal Medicine

Lipoproteins and Cardiovascular Health

article

In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d

Tess Allan, L. Kristin Newby

January 1, 2026article en

Abstract

No abstract available for this paper.

Annals of Internal MedicineVol. 179(1)

Duke University (US)

Zero hunger

Openalex Percentile: Top 95%

Lipoproteins and Cardiovascular Health

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d — Tess Allan, L. Kristin Newby · Annals of Internal Medicine (2026) | TGRS Research Map | TGRS